Medical devices, healthcare technology and the business of care
PMA approval · P140030

ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM

Biotronik AG · Decision date Dec 17, 2015

MEDTECHLEDGER EXPLANATIONP140030

What did the FDA approve?

The FDA database entry for P140030 records a December 17, 2015 approval decision for the Astron Peripheral Self-Expanding Nitinol Stent System from Biotronik AG. The device is categorized as an iliac stent under product code NIO and specialty Cardiovascular.

The approval statement describes the indicated use as improving luminal diameter in patients with iliac atherosclerotic lesions in vessel reference diameters between 4.3 mm and 9.5 mm and lesion lengths up to 105 mm. The entry does not identify a supplement type or supplement reason, and no additional clinical performance data are included.

FDA approval order statement

APPROVAL FOR THE ASTRON PERIPHERAL SELF-EXPANDING STENT SYSTEM. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETERIN PATIENTS WITH ILIAC ATHEROSCLEROTIC LESIONS IN VESSEL REFERENCE DIAMETERS BETWEEN 4.3MM AND9.5MM AND LESION LENGTHS UP TO 105MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Dec 17, 2015

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140030
Regulatory pathway
Premarket approval application
Applicant
Biotronik AG
Product code
NIO
Decision code
APPR
Decision date
Dec 17, 2015
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Applicant
Biotronik AG
Product code
NIO
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140030 received

    Application receipt date recorded by FDA.

  2. P140030 · FDA decision

    APPR

  3. P140030/S025 · Related supplement

    Astron Peripheral Self-Expanding Nitinol Stent System

Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140030

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik AGPMA supplementSep 11, 2026FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA
Medtronic Vascular, Inc.PMA approvalJun 8, 2004FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ackerstrasse 6, Bülach, 8180

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records